Guangzhou Concord Cancer Center
广州泰和肿瘤医院
Guangzhou Concord Cancer Center (Guangzhou Concord) is a tertiary specialized oncology hospital owned by Concord Medical Technology Development Group. It is located in the Sino-Singapore Guangzhou Knowledge City, Huangpu District, Guangzhou, with a planned construction area of 100,000 square meters. It is the designated medical institution for medical insurance. From the beginning of the planning and design, Guangzhou Concord has been cooperating with top international medical institutions (MD Anderson Cancer Center and Mayo Clinic) and many other top medical institutions in Guangdong Province. Internationally leading medical quality control system and operation management system have been set up while an in-hospital and inter-hospital multidisciplinary joint diagnosis and treatment MDT (Multi-Disciplinary Team) platform is established. Our hospital follows high-standard medical protocols, diagnostic and treatment guidelines and pathways, providing international, standardized and individualized services to cancer patients in accordance with the Multi-Disciplinary Team platform. The hospital provides medical services of radiotherapy, oncology, surgery, internal medicine, gynecology, nuclear medicine, anesthesiology, medical imaging, pathology and laboratory examinations and others. It is a ‘five-in-one’ cancer prevention and treatment center featuring clinical therapy, cancer prevention, clinical research, specialty training and remote consultation, providing a wide range of services, including surgery, photon and proton therapy, chemotherapy, target therapy, immunotherapy, as well as psychological intervention, nutritional therapy, rehabilitation and chronic disease management. Guangzhou Concord is committed to building a highland of medical technology and medical ethics. Our clinical and operation team practice ‘patient-centred’ philosophy, providing multi-level and differentiated services to local families, Hong Kong, Macao, Taiwan and international patients, and overseas returnees. A diversified payment system and service process have been established to facilitate patients' access to healthcare services. We endeavor to benefit more patients and to be the most trusted partner in the fight against cancer.
- Est. 2021
- 14 departments
